Named DermPharCos and based in Hamburg, Germany, the company aims to help global industry players to develop more effective and targeted skin care products.
Dr. Callaghan says that the primary focus of the business will be to help develop strategic intelligence for enhanced innovation, together with developing and defining product claims as well as providing scientific integrity to enhance media-driven marketing and promotional campaigns.
Covering all key dermatological categories
Key product categories that the business will cover will include cosmetic, dermatological and wound care products, while services will also extend to analysis of the market, including the study of competitor products.
In recent years EU regulations and advertising standards have become increasingly strict with regards to scientific claims made about a wide variety of personal care products, especially in the skin care category.
Providing accurate science-based product claims
In particular, claims about anti-ageing products have been highly scrutinised, with regulatory authorities demanding that specific claims made about the efficacy of such products should be sufficiently backed up by scientific evidence.
Dr. Callaghan is a biochemist by training and has served more than 20 years in senior positions working for leading personal care players including Unilever, Johnshon & Johnson and Evonik.
Her most recent position was as director of business development and scientific affairs for proDERM, a company that provides dermatological consultancy services to the industry based on scientific principles.
